# Commission Regulation (EU) No 1070/2010 of 22 November 2010 amending Directive 2008/38/EC by adding to the list of intended uses as a particular nutritional purpose the support of the metabolism of the joints in the case of osteoarthritis in dogs and cats (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Part B of Annex I to Directive 2008/38/EC, the following row is inserted between the row of the particular nutritional purpose ‘Support of skin function in the case of dermatosis and excessive loss of hair’ and the row of the particular nutritional purpose ‘Reduction of the risk of milk fever’:
Particular nutritional purpose
Essential nutritional characteristics
Species or category of animal
Labelling declarations
Recommended length of time for use
Other provisions
‘Support of the metabolism of joints in the case of osteoarthritis
Dogs:
Minimum dry matter content of total omega-3 fatty acids 3,3 % and of eicosapentaenoic acid (EPA) 0,38 %.
Adequate level of vitamin E.
Cats:
Minimum dry matter content of total omega-3 fatty acids 1,2 % and of docosahexaenoic acid (DHA) 0,28 %.
Increased levels of methionine and manganese.
Adequate level of vitamin E.
Dogs and cats
Dogs:
Total omega-3 fatty acids
Total EPA
Total vitamin E
Cats:
Total omega-3 fatty acids
Total DHA
Total methionine
Total manganese
Total vitamin E
Initially up to 3 months
It is recommended that a veterinary surgeon’s opinion be sought before use or before extending the period of use.’

---
Source: https://www.legislation.gov.uk/eur/2010/1070/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2010-1070/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.